Chemomab Therapeutics (CMMB) Share-based Compensation (QoQ) (2018 - 2023)
Chemomab Therapeutics (CMMB) Share-based Compensation (QoQ) (2018 - 2023) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | Chemomab Therapeutics | 13.62 Mn | 3.25 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2023 | 83.08% |
| Sep 30, 2023 | -79.66% |
| Jun 30, 2023 | 32.02% |
| Mar 31, 2023 | -34.59% |
| Dec 31, 2022 | -11.48% |
| Sep 30, 2022 | 9.86% |
| Jun 30, 2022 | -12.93% |
| Mar 31, 2022 | -13.29% |
| Dec 31, 2021 | 128.57% |
| Sep 30, 2021 | -16.32% |
| Jun 30, 2021 | 1,125.58% |
| Mar 31, 2021 | -68.38% |
| Dec 31, 2020 | 491.30% |
| Sep 30, 2020 | -17.86% |
| Jun 30, 2020 | -39.13% |
| Mar 31, 2020 | -48.31% |
| Dec 31, 2019 | -72.27% |
| Sep 30, 2019 | -12.77% |
| Jun 30, 2019 | -3.16% |
| Mar 31, 2019 | 4.40% |